Exair® Versus Native Tissue Repair for Prolapse

TerminatedOBSERVATIONAL
Enrollment

79

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Pelvic Organ Prolapse
Interventions
DEVICE

Exair Prolapse Repair System

PROCEDURE

Total Native Tissue Repair

Trial Locations (14)

12208

Albany Medical Center, Albany

13790

United Health Services, Johnson City

18103

The Institute for Female Pelvic Medicine and Reconstructive Surgery, Allentown

24073

Carillion Clinic OB/GYN, Christiansburg

27103

Lyndhurst Clinical Research, Winston-Salem

Novant Health Clinical Research, Winston-Salem

31405

Progressive GYN Center, Savannah

46825

Women's Health Advantage, Fort Wayne

48124

Advanced Urogynecology of Michigan, Dearborn

55109

Minnesota Women's Care, Maplewood

07960

Atlantic Urogynecology Associates, Morristown

08540

Princeton Urogynecology, Princeton

05495

Vermont Urogynecology Associates, P.C., Williston

J1H 5N4

CHUS-CRC, Sherbrooke

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Coloplast A/S

INDUSTRY

NCT02162628 - Exair® Versus Native Tissue Repair for Prolapse | Biotech Hunter | Biotech Hunter